EPM News
Stephen Hawking to open rare disease summit
Event: Professor Stephen Hawking will open the inaugural Cambridge Rare Disease Summit, at the Cambridge Judge Business School on Monday 14 September more »
Sep 10, 2015 4:26 PM News
Quit-smoking drug does not lead to heart disease or depression, says study
Varenicline helps smokers to quit but does not increase their risk of heart attack and depression says research published in The Lancet Respiratory Medicine more »
Sep 10, 2015 2:23 PM News
New delivery method gets drugs into the lungs
Researchers at Columbia University in New York have developed a method that can target delivery of very small volumes of drugs into the lung more »
Sep 10, 2015 10:24 AM News
Tribology data available for drug delivery devices
RTP Company, a compounder of custom engineered thermoplastics, is offering tribology data from a friction test to help designers of drug delivery devices select the best possible material for single-use applications more »
Sep 10, 2015 9:58 AM News
FDA grants fast track designation for Iclaprim
The Food and Drug Administration (FDA) has granted fast track designation for Motif Bio’ iclaprim intravenous (IV) drug to treat acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP) more »
Sep 9, 2015 3:56 PM News
Anti-overdose nasal spray on FDA fast-track
An anti-overdose drug nasal spray has been submitted for expedited review by the Food and Drug Administration (FDA) more »
Sep 8, 2015 11:21 AM News
Microfish act as proof-of-concept for sensing toxins
Nanoengineers from the nanoengineering department at the University of California, San Diego (UC San Diego) have created 3D printed micro robots in the form of a small fish, called micro fish, as a proof-of-concept for detoxing and sensing toxins more »
Sep 8, 2015 10:23 AM News
Putting quality first in development and manufacturing
Capsugel’s Steven Facer says prioritisation of quality and regulatory compliance from the start is key to achieving long-term gains for emerging markets more »
Sep 8, 2015 9:41 AM Opinion
In Profile: Angle's Andrew Newland
Angle’s Andrew Newland talks to EPM about the high level of interest from across the globe in the company’s cell separation technology, which captures cancer cells circulating in the blood and harvests those cells for analysis more »
Sep 8, 2015 8:56 AM Opinion
Event: BioInfect
BioInfect will take place on 10 November 2015 at Alderley Park, Cheshire more »
Sep 7, 2015 11:54 AM News
Novartis acquires drug to develop treatment for MS
Novartis has acquired all remaining rights to GlaxoSmithKline’s (GSK) Ofatumumab more »
Sep 7, 2015 11:42 AM News
SSB and GE sign worldwide supply agreement
Sartorius Stedim Biotech (SSB) and GE Healthcare’s Life Sciences business (GE), have entered into a worldwide OEM supply agreement for SSB’s membrane adsorber purification technology, Sartobind more »
Sep 7, 2015 11:22 AM News
HRA Pharma launches online resource for pharmacists
HRA Pharma UK and Ireland has launched ellaonepharmacist.co.uk more »
Sep 7, 2015 11:09 AM News
FDA approves drug to treat children with ITP
The US Food and Drug Association (FDA) expands use of Novartis drug Promacta to include treatment of children ages one and older with chronic immune thrombocytopenia (ITP) more »
Sep 7, 2015 10:47 AM News
Data breaches in the pharmaceutical sector at 60%
The extent of data breaches in the pharmaceutical sector has been revealed with almost one quarter being hacked and 60% admitting to losing important data more »
Sep 4, 2015 3:03 PM News
Single polymer pill to deliver entire drug course
Emily Hughes looks at how scientists in the US have designed a single pill made from a polymer gel that could deliver an entire treatment in a single dose more »
Sep 3, 2015 11:05 AM News
Sygnature scientists are named inventors on over 50 drug patents
Dr. Paul Clewlow, Sygnature Discovery, talks to EPM about the company’s successful track record in discovering medicines for the benefit of “patients with debilitating diseases such as cancer” more »
Sep 3, 2015 10:14 AM Opinion
Solving the global benefit-risk assessment dilemma
Professor Sam Salek, School of Medical and Life Sciences, University of Hertfordshire, calls for a “universal framework” to speed up the disjointed decision-making process around the commissioning of new drugs more »
Sep 3, 2015 8:50 AM Opinion
Odomzo gains approval to treat laBCC
Novartis drug Odomzo gains approval for locally advanced basal cell carcinoma, providing non-invasive therapy for patients more »
Sep 2, 2015 11:35 AM News
Sanofi and Google Life Sciences to improve diabetes health
Sanofi and the life sciences team at Google are teaming up to improve care and outcomes for people with type 1 and type 2 diabetes more »
Sep 1, 2015 2:39 PM News